Nuvectis Pharma, Inc.(NVCT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVCT Nuvectis Pharma, Inc.

已收盘 01-14 16:00:00 EST

8.41

+0.10

+1.20%

盘后8.41

+0.000.00%

16:04 EST

最高8.46	最低8.05	成交量3.99万
今开8.32	昨收8.31	日振幅4.92%
总市值2.15亿	流通市值1.22亿	总股本2,561万
成交额33.18万	换手率0.27%	流通股本1,454万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVCT","market":"US","secType":"STK","nameCN":"Nuvectis Pharma, Inc.","latestPrice":8.41,"timestamp":1768424400000,"preClose":8.31,"halted":0,"volume":39880,"hourTrading":{"tag":"盘后","latestPrice":8.41,"preClose":8.41,"latestTime":"16:04 EST","volume":158,"amount":1328.78,"timestamp":1768424646142},"delay":0,"changeRate":0.012033694344163615,"floatShares":14536600,"shares":25614896,"eps":-1.359454,"marketStatus":"已收盘","change":0.1,"latestTime":"01-14 16:00:00 EST","open":8.32,"high":8.4592,"low":8.05,"amount":331766.3062,"amplitude":0.049242,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.359454,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1768467600000},"marketStatusCode":5,"adr":0,"listingDate":1638334800000,"exchange":"NASDAQ","adjPreClose":8.31,"postHourTrading":{"tag":"盘后","latestPrice":8.41,"preClose":8.41,"latestTime":"16:04 EST","volume":158,"amount":1328.78,"timestamp":1768424646142},"volumeRatio":0.436205,"impliedVol":0.7708,"impliedVolPercentile":0.2709},"requestUrl":"/m/hq/s/NVCT","defaultTab":"news","newsList":[{"id":"1193391794","title":"Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1193391794","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1193391794?lang=zh_cn&edition=full","pubTime":"2025-12-17 20:03","pubTimestamp":1765972988,"startTime":"0","endTime":"0","summary":"Nuvectis Pharma 宣布启动 Nxp900 与 Osimertinib 联合治疗非小细胞肺癌的 1B 相研究","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2559663958","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.13%报6.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2559663958","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559663958?lang=zh_cn&edition=full","pubTime":"2025-08-14 00:43","pubTimestamp":1755103414,"startTime":"0","endTime":"0","summary":"北京时间2025年08月14日00时43分，Nuvectis Pharma, Inc.股票出现异动，股价急速下挫5.13%。截至发稿，该股报6.47美元/股，成交量5.5539万股，换手率0.22%，振幅6.00%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.42%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081400433494e18cd7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081400433494e18cd7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2558661429","title":"Nuvectis Pharma, Inc.盘中异动 大幅上涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558661429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558661429?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:58","pubTimestamp":1754927930,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时58分，Nuvectis Pharma, Inc.股票出现波动，股价急速上涨5.17%。截至发稿，该股报6.31美元/股，成交量5.9103万股，换手率0.23%，振幅5.17%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5746.78%、541.06%、184.05%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235850a4824909&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235850a4824909&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2558681716","title":"Nuvectis Pharma, Inc.2025财年第二财季实现净利润-6.33百万美元，同比减少42.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558681716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558681716?lang=zh_cn&edition=full","pubTime":"2025-08-11 00:01","pubTimestamp":1754841682,"startTime":"0","endTime":"0","summary":"8月11日，Nuvectis Pharma, Inc.公布财报，公告显示公司2025财年第二财季净利润为-6.33百万美元，同比减少42.89%；其中营业收入为0.00美元，每股基本收益为-0.30美元。从资产负债表来看，Nuvectis Pharma, Inc.总负债10.14百万美元，其中短期债务0.00美元，资产负债比为2.67，流动比率为2.67。机构评级：截至2025年8月11日，当前有6家机构对Nuvectis Pharma, Inc.目标价做出预测，其中目标均价为18.17美元，其中最低目标价为10.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000322a4805739&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811000322a4805739&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT"],"gpt_icon":0},{"id":"2557562118","title":"Nuvectis Pharma, Inc.盘中异动 早盘股价大跌5.34%报6.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557562118","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557562118?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:51","pubTimestamp":1754578277,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日22时51分，Nuvectis Pharma, Inc.股票出现波动，股价快速下挫5.34%。截至发稿，该股报6.12美元/股，成交量5.7244万股，换手率0.27%，振幅7.08%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts 、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Palisade Bio, Inc.、Bioxcel Therapeutics, Inc.、Processa Pharmaceuticals, Inc.较为活跃，换手率分别为1672.14%、126.64%、82.42%，振幅较大的相关个股有Palisade Bio, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为92.00%、64.39%、39.49%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072251179739d0a6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508072251179739d0a6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2557319870","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557319870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557319870?lang=zh_cn&edition=full","pubTime":"2025-08-06 03:27","pubTimestamp":1754422072,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日03时27分，Nuvectis Pharma, Inc.股票出现波动，股价快速下跌5.08%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为3.59%。其相关个股中，Y-Mabs Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Shattuck Labs, Inc.、Psyence Biomedical Ltd.较为活跃，换手率分别为632.39%、191.59%、180.99%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Bioxcel Therapeutics, Inc.，振幅分别为67.96%、66.93%、48.03%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806032752a6d4fe1d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806032752a6d4fe1d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2557133306","title":"Nuvectis Pharma, Inc.盘中异动 下午盘急速拉升5.15%报7.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557133306","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557133306?lang=zh_cn&edition=full","pubTime":"2025-08-05 01:15","pubTimestamp":1754327738,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日01时15分，Nuvectis Pharma, Inc.股票出现异动，股价大幅上涨5.15%。截至发稿，该股报7.15美元/股，成交量5.1706万股，换手率0.25%，振幅5.13%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.32%。其相关个股中，Psyence Biomedical Ltd.、Neurosense Therapeutics Ltd C/Wts 10/11/2026 、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5539.63%、1426.98%、642.42%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508050115389733566c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508050115389733566c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2555390728","title":"Nuvectis Pharma, Inc.股价重挫16.50% 市值跌2173.23万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555390728","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555390728?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:32","pubTimestamp":1753968731,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时32分，Nuvectis Pharma, Inc.股票出现波动，股价大幅跳水16.50%。截至发稿，该股报6.30美元/股，成交量8.879万股，换手率0.42%，振幅5.06%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Soligenix, Inc.、Psyence Biomedical Ltd.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Onconetix, Inc.、Psyence Biomedical Ltd.、Soligenix, Inc.较为活跃，换手率分别为3631.51%、1769.23%、1724.71%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Psyence Biomedical Ltd.、Soligenix, Inc.，振幅分别为32.00%、17.78%、13.60%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213211a46db37c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213211a46db37c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2551182318","title":"Nuvectis Pharma, Inc.盘中异动 早盘急速上涨6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551182318","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551182318?lang=zh_cn&edition=full","pubTime":"2025-07-14 21:46","pubTimestamp":1752500805,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日21时46分，Nuvectis Pharma, Inc.股票出现异动，股价大幅拉升6.60%。截至发稿，该股报8.40美元/股，成交量1.5212万股，换手率0.07%，振幅5.84%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Dare Bioscience, Inc.、Promis Neurosciences Inc.、Rani Therapeutics Holdings, Inc.涨幅较大，Windtree Therapeutics, Inc.、Dare Bioscience, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为1713.40%、449.31%、175.72%，振幅较大的相关个股有Promis Neurosciences Inc.、Dare Bioscience, Inc.、Biomx Inc.，振幅分别为112.70%、100.99%、83.49%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214645a44a24a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714214645a44a24a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2550659604","title":"Nuvectis Pharma, Inc.盘中异动 早盘快速上涨5.01%报7.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550659604","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550659604?lang=zh_cn&edition=full","pubTime":"2025-07-09 23:06","pubTimestamp":1752073590,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日23时06分，Nuvectis Pharma, Inc.股票出现波动，股价急速拉升5.01%。截至发稿，该股报7.96美元/股，成交量1.8563万股，换手率0.09%，振幅3.95%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 涨幅较大，Calidi Biotherapeutics, Inc.、Kazia Therapeutics Limited、Mustang Bio, Inc.较为活跃，换手率分别为1231.51%、718.98%、542.90%，振幅较大的相关个股有Calidi Biotherapeutics, Inc.、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 、Prokidney Corp.，振幅分别为208.96%、112.02%、74.53%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230630a69fb0ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709230630a69fb0ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2549557775","title":"Nuvectis Pharma, Inc.盘中异动 大幅拉升5.44%报7.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557775","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549557775?lang=zh_cn&edition=full","pubTime":"2025-07-08 03:55","pubTimestamp":1751918109,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日03时55分，Nuvectis Pharma, Inc.股票出现异动，股价大幅拉升5.44%。截至发稿，该股报7.95美元/股，成交量9.6707万股，换手率0.46%，振幅5.84%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。其相关个股中，Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Cognition Therapeutics, Inc.涨幅较大，Mustang Bio, Inc.、Artelo Biosciences, Inc.、Sonnet Biotherapeutics Holdings, Inc.较为活跃，换手率分别为6303.96%、1290.59%、939.60%，振幅较大的相关个股有Mustang Bio, Inc.、Pelthos Therapeutics Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为316.81%、233.18%、103.43%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080355109539e89e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507080355109539e89e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2518222695","title":"Nuvectis Pharma, Inc.盘中异动 股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222695","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222695?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:43","pubTimestamp":1741614229,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时43分，Nuvectis Pharma, Inc.股票出现异动，股价急速上涨5.27%。截至发稿，该股报7.30美元/股，成交量2.9377万股，换手率0.13%，振幅5.48%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Trevi Therapeutics, Inc.、Checkpoint Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2382.81%、559.93%、84.17%，振幅较大的相关个股有Scisparc Ltd.、Impact Biomedical, Inc.、Trevi Therapeutics, Inc.，振幅分别为40.24%、28.59%、25.35%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214349a26a295e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214349a26a295e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2516677943","title":"Nuvectis Pharma, Inc.盘中异动 早盘股价大涨5.05%报6.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677943?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:43","pubTimestamp":1741099391,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时43分，Nuvectis Pharma, Inc.股票出现波动，股价快速上涨5.05%。截至发稿，该股报6.45美元/股，成交量4611股，换手率0.02%，振幅5.37%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Protagenic Therapeutics, Inc.、Capricor Therapeutics, Inc.涨幅较大，Aeon Biopharma, Inc.、Windtree Therapeutics, Inc.、Protagenic Therapeutics, Inc.较为活跃，换手率分别为1120.39%、1104.72%、461.59%，振幅较大的相关个股有Celularity Inc C/Wts 16/07/2026 、Hepion Pharmaceuticals, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为37.67%、22.25%、21.85%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431196394834&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431196394834&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0},{"id":"2516580866","title":"Nuvectis Pharma, Inc.盘中异动 早盘快速跳水5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516580866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516580866?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:59","pubTimestamp":1741017564,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时59分，Nuvectis Pharma, Inc.股票出现波动，股价大幅跳水5.01%。截至发稿，该股报6.36美元/股，成交量3.0621万股，换手率0.13%，振幅5.98%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.51%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Radiopharm Theranostics Limited涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为3027.60%、142.96%、134.56%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Pliant Therapeutics, Inc.，振幅分别为206.20%、70.53%、50.09%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235924989a2605&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303235924989a2605&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2516552208","title":"Nuvectis Pharma, Inc.2024财年实现净利润-19.00百万美元，同比增加14.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516552208","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516552208?lang=zh_cn&edition=full","pubTime":"2025-03-02 00:01","pubTimestamp":1740844860,"startTime":"0","endTime":"0","summary":"3月2日，Nuvectis Pharma, Inc.公布财报，公告显示公司2024财年净利润为-19.00百万美元，同比增加14.65%；其中营业收入为0.00美元，每股基本收益为-1.11美元。从资产负债表来看，Nuvectis Pharma, Inc.总负债8.89百万美元，其中短期债务0.00美元，资产负债比为2.10，流动比率为2.10。机构评级：截至2025年3月2日，当前有3家机构对Nuvectis Pharma, Inc.目标价做出预测，其中目标均价为16.33美元，其中最低目标价为11.00美元，最高目标价为20.00美元。其产品线包括NXP800、NXP900。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000118abe2c59a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250302000118abe2c59a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT"],"gpt_icon":0},{"id":"2514856197","title":"Nuvectis Pharma, Inc.盘中异动 早盘急速上涨6.21%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856197","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856197?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:35","pubTimestamp":1740580504,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时35分，Nuvectis Pharma, Inc.股票出现异动，股价快速拉升6.21%。截至发稿，该股报7.36美元/股，成交量2350股，换手率0.01%，振幅0.00%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。其相关个股中，Sab Biotherapeutics Inc C/Wts 22/10/2026 、Channel Therapeutics Corporation、Immunoprecise Antibodies Ltd.涨幅较大，Organovo Holdings, Inc.、Cns Pharmaceuticals, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为127.52%、95.24%、76.83%，振幅较大的相关个股有Humacyte Inc C/Wts 27/08/2026 、Nutriband Inc C/Wts 、Channel Therapeutics Corporation，振幅分别为38.41%、17.13%、16.86%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505a254f771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223505a254f771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2514014642","title":"HC Wainwright & Co.：维持Nuvectis Pharma(NVCT.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514014642","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514014642?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:52","pubTimestamp":1740502323,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：维持Nuvectis Pharma(NVCT.US)评级，由买入调整至买入评级, 目标价由21.00美元调整至11.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26005248385931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NVCT"],"gpt_icon":0},{"id":"2514012679","title":"Nuvectis Pharma, Inc.盘中异动 临近午盘急速下挫5.03%报6.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514012679","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514012679?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:44","pubTimestamp":1740501845,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时44分，Nuvectis Pharma, Inc.股票出现异动，股价快速下挫5.03%。截至发稿，该股报6.99美元/股，成交量4.2608万股，换手率0.19%，振幅4.76%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Organovo Holdings, Inc.、Gt Biopharma, Inc.、Silexion Therapeutics Corp较为活跃，换手率分别为1464.35%、1120.54%、931.53%，振幅较大的相关个股有Organovo Holdings, Inc.、Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为241.19%、87.83%、66.67%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260044069892680c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502260044069892680c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2511137316","title":"Nuvectis Pharma, Inc.盘中异动 大幅拉升5.76%报7.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511137316","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511137316?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:12","pubTimestamp":1739553159,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时12分，Nuvectis Pharma, Inc.股票出现异动，股价快速拉升5.76%。截至发稿，该股报7.35美元/股，成交量9.1569万股，换手率0.41%，振幅5.47%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Moleculin Biotech, Inc.、Allogene Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为2869.01%、749.19%、581.98%，振幅较大的相关个股有Moleculin Biotech, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为71.65%、70.63%、66.45%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011239abcf28e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215011239abcf28e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCT","BK4139"],"gpt_icon":0},{"id":"2510866686","title":"Nuvectis Pharma, Inc.盘中异动 股价大跌5.37%报6.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510866686","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510866686?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:59","pubTimestamp":1739199546,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时59分，Nuvectis Pharma, Inc.股票出现异动，股价急速下挫5.37%。截至发稿，该股报6.35美元/股，成交量9325股，换手率0.04%，振幅6.41%。Nuvectis Pharma, Inc.股票所在的生物技术行业中，整体涨幅为0.32%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2265.08%、1425.61%、840.03%，振幅较大的相关个股有Biodexa Pharmaceuticals Plc、Ocean Biomedical, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为59.71%、51.99%、39.57%。Nuvectis Pharma, Inc.公司简介：Nuvectis Pharma Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225906a240a889&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210225906a240a889&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NVCT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.nuvectis.com","stockEarnings":[{"period":"1week","weight":0.0134},{"period":"1month","weight":0.0949},{"period":"3month","weight":0.3645},{"period":"6month","weight":0.0453},{"period":"1year","weight":0.4303},{"period":"ytd","weight":0.1007}],"compareEarnings":[{"period":"1week","weight":0.0028},{"period":"1month","weight":0.0176},{"period":"3month","weight":0.043},{"period":"6month","weight":0.1047},{"period":"1year","weight":0.1933},{"period":"ytd","weight":0.0174}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Nuvectis Pharma, Inc.于2020年7月27日根据特拉华州法律注册成立。该公司是一家生物制药公司，专注于开发用于治疗严重未满足的肿瘤医疗需求的创新精准药物。公司的发展战略采用基于精准医学的方法，将与致癌驱动因素、通路成瘾和其促癌因素相关的关键科学见解转化为选择性、强效和高选择性的抗癌药物。该公司相信，这些进步为靶向疗法的现代发展奠定了基础，这将使基于肿瘤基因特征而非肿瘤组织学的抗癌疗法的发现和开发成为可能。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.136742},{"month":2,"riseRate":0.666667,"avgChangeRate":0.165257},{"month":3,"riseRate":0.75,"avgChangeRate":0.129194},{"month":4,"riseRate":0.75,"avgChangeRate":0.042967},{"month":5,"riseRate":0.75,"avgChangeRate":0.205701},{"month":6,"riseRate":0,"avgChangeRate":-0.153353},{"month":7,"riseRate":0.25,"avgChangeRate":-0.099906},{"month":8,"riseRate":0.5,"avgChangeRate":-0.005612},{"month":9,"riseRate":0,"avgChangeRate":-0.100626},{"month":10,"riseRate":0.5,"avgChangeRate":-0.011793},{"month":11,"riseRate":0.25,"avgChangeRate":-0.090389},{"month":12,"riseRate":0.75,"avgChangeRate":0.071233}],"exchange":"NASDAQ","name":"Nuvectis Pharma, Inc.","nameEN":"Nuvectis Pharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Nuvectis Pharma, Inc.(NVCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Nuvectis Pharma, Inc.(NVCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Nuvectis Pharma, Inc.,NVCT,Nuvectis Pharma, Inc.股票,Nuvectis Pharma, Inc.股票老虎,Nuvectis Pharma, Inc.股票老虎国际,Nuvectis Pharma, Inc.行情,Nuvectis Pharma, Inc.股票行情,Nuvectis Pharma, Inc.股价,Nuvectis Pharma, Inc.股市,Nuvectis Pharma, Inc.股票价格,Nuvectis Pharma, Inc.股票交易,Nuvectis Pharma, Inc.股票购买,Nuvectis Pharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Nuvectis Pharma, Inc.(NVCT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Nuvectis Pharma, Inc.(NVCT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}